MOLN
Molecular Partners AG ADR
NASDAQ: MOLN · HEALTHCARE · BIOTECHNOLOGY
$4.23
-4.94% today
Updated 2026-04-30
Market cap
$162.74M
P/E ratio
—
P/S ratio
158.42x
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$3 – $5
Volume
0.0M
WallStSmart proprietary scores
21
out of 100
Grade: F
Strong Sell
Investment rating
3.7
Growth
D5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$11.11
+162.65%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-10.81M
- Revenue declining -100.00% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $189.56M | $7.04M | $4.97M | $0.00 | $0.00 |
| Net income | $117.85M | $-61.98M | $-54.04M | $-61.65M | $-12.65M |
| EPS | — | — | — | — | $-2.10 |
| Free cash flow | $117.15M | $-59.58M | $-59.97M | $-51.97M | $-10.81M |
| Profit margin | 62.17% | -880.70% | -1,087.38% | — | — |
Peer comparison
Smart narrative
Molecular Partners AG ADR trades at $4.23. Our Smart Value Score of 21/100 indicates the stock is weak.
Frequently asked questions
What is Molecular Partners AG ADR's stock price?
Molecular Partners AG ADR (MOLN) trades at $4.23.
Is Molecular Partners AG ADR overvalued?
Smart Value Score 21/100 (Grade F, Strong Sell).
What is the price target of Molecular Partners AG ADR (MOLN)?
The analyst target price is $11.11, representing +162.6% upside from the current price of $4.23.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio158.42x
ROE-55.50%
Beta0.74
50D MA$4.51
200D MA$4.10
Shares out0.04B
Float0.02B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—